ELV approaching significant overhead resistance

40
Elevance Health Inc. (ELV) approaching significant overhead resistance, able to absorb monthly buying pressures.

From here, (ELV) can reject and fall lower to channel support, eliciting losses of 15% - 20% over the following 2 - 3 months.

Inversely, a weekly settlement above resistance would place (ELV) into a buy-signal where gains of 15% - 20% would be expected over the following 2 - 5 months.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.